The Dorsey 4D Symposium gathers leaders in the life sciences industry who discuss critical issues and trends affecting emerging and established life sciences companies and their investors. Join us as we explore the “4Ds” of the life sciences industry – devices, diagnostics, drugs and digital health.

For more information, and agenda, visit


  • Howard Root, CEO, Vascular Solutions, Inc.
  • Brian Adams, General Counsel & Secretary, Keryx Biopharmaceuticals, Inc.
  • Dr. Steve Allen, CEO, DNAe Group Holdings
  • Josh Baltzell, Venture Partner, SightLine Partners
  • Ted Driscoll, PhD, Partner – Digital Healthcare Lead, Claremont Creek Ventures
  • Victor C. Esch, Ph.D, President/CEO, DNA Electronics Inc.
  • Stephen Hurst, JD, Founder, Director, President and CEO, Savant HWP, Inc.
  • Catherine Jennings, Director, New Business Development - Peripheral Interventions Division, Boston Scientific Corporation
  • Mark Myhra, Senior Corporate Counsel, Boston Scientific Corporation
  • Tom Ressemann, President and CEO, Amphora Medical, Inc.
  • Tamara Sniffen, Vice President, Integrated Business Planning, Stryker
  • Kurt Waltenbaugh, Founder & CEO, Carrot Health, Inc.